Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver
NCT00149396
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Liver Neoplasms
Interventions
DRUG:
NV1020
Sponsor
MediGene